Functional Concept
Marea Therapeutics Launches with $190M Funding to Combat Adipose Dysfunction
Marea Therapeutics, Adipose Dysfunction, $190M Funding, Biotech, Healthcare
Gilead’s Magrolimab Ineffective, Linked to Increased Risk of Death in MDS Patients
Gilead, Magrolimab, MDS, Myelodysplastic Syndrome, Cancer Treatment, Clinical Trials, Safety Concerns
Skye Bioscience Abandons Eye Disease Pipeline, Shifts Focus to Obesity Treatment After Phase 2a Trial Failure
Skye Bioscience, eye disease, Phase 2a trial, obesity treatment, stock price, biotech company
Biomea’s Early-Stage Diabetes Drug Placed on Full Clinical Hold, Stock Plummets
Biomea, diabetes, clinical hold, FDA, BMF-219, liver toxicity, stock crash
Boehringer Ingelheim and Zealand Unveil Promising Fibrosis Data from Mid-Stage MASH Trial
Boehringer Ingelheim, Zealand, fibrosis, MASH trial, mid-stage, Phase II data, liver scarring, treatment
ASCO: AbbVie Revamps ADC Portfolio to Replace Chemotherapy
ASCO, AbbVie, ADCs, Chemotherapy, Rova-T, Teliso-V, Cancer Treatment
Lilly’s Tirzepatide Wins NICE Endorsement for Obesity Treatment with BMI and Weight Loss Conditions
Lilly, tirzepatide, NICE endorsement, obesity treatment, BMI, weight loss, Zepbound, Mounjaro, GLP-1 receptor agonist
Moon Surgical’s Maestro Robotic Laparoscopy Platform Receives FDA Clearance for Commercial Use
Moon Surgical, Maestro, Robotic Laparoscopy, FDA Clearance, Commercial Use, Surgical Innovation
Amarin Names New CEO Aaron Berg Following Patrick Holt’s Resignation
Amarin, CEO, Patrick Holt, Aaron Berg, Resignation, Leadership Transition